BioInvent International AB Announces that its CFO will Retire in 2027
(PR-inside.com) LUND, SE / ACCESS Newswire / October 12, 2026 / BioInvent International AB ("BioInvent") (STO:BINV) , a leader in the discovery of novel immunomodulatory antibodies, today announced that the company's CFO, Stefan Ericsson, has decided to retire when he turns 64 in January 2027. The process of appointing…
Short extract only — this publisher licenses its text. Read the full release at the source.
Free plan · Plus CA$29 or Pro CA$99/month


